Who Decides? Kerwin Brandt on Patient Choice in Skin Cancer

When someone is diagnosed with non-melanoma skin cancer, who should decide how it's treated?

Kerwin Brandt, CEO of SkinCure Oncology, makes the case that when an effective non-surgical option exists, the choice belongs to the patient.

Scott and Kerwin explore:

What patients should ask about non-surgical treatment, and what dermatologists should be telling them Why image guidance changes outcomes in superficial radiation therapy The "laser graveyard," and why so much expensive equipment ends up unused in the back of the practice Why Kerwin believes the standard of care for skin cancer is about to shift, just as it did for breast and prostate cancer Technology on the horizon that could show patients exactly what surgery would involve before they decide If you lead a dermatology practice, this episode leaves you with a question worth asking: is every patient hearing about every appropriate option before a decision is made?

Full disclosure: SkinCure Oncology, the company behind GentleCure, sponsors The Distinctive Dermatologist.

This episode is for informational purposes only and is not medical advice. Patients should discuss treatment options with their physician.